Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest Manufacturers of America Stories

2014-03-12 12:28:22

I'm In campaign to educate underrepresented populations about clinical trial participation WASHINGTON, March 12, 2014 /PRNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) and the National Minority Quality Forum today announced a first-of-its-kind national campaign to help increase diversity in clinical trials. The I'm In campaign will raise awareness about the importance of clinical research and encourage greater participation by diverse patient...

2013-07-08 16:26:23

WASHINGTON, July 8, 2013 /PRNewswire-USNewswire/ -- The National Minority Quality Forum (The Forum) announces that the Pharmaceutical Research and Manufacturers of America (PhRMA) has joined The Forum's collaboration with Microsoft to launch The National Clinical Trial Network (NCTN). PhRMA represents the country's leading innovative biopharmaceutical research and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer,...

2013-04-22 08:29:54

SAN DIEGO, April 22, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, announced today that Michael Narachi, president and chief executive officer, has been named to the Board of Directors of the Pharmaceutical Research and Manufacturers of America (PhRMA). Narachi will serve as a director for a term of two years. PhRMA represents the country's leading innovative biopharmaceutical research and biotechnology...

2013-04-12 12:24:37

SAN DIEGO, April 12, 2013 /PRNewswire-USNewswire/ -- Robert J. Hugin, chairman and CEO of Celgene Corporation, was elected chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) today at the trade association's annual meeting. Also elected were Ian C. Read, president and CEO of Pfizer Inc, as chairman-elect of the PhRMA Board of Directors, and Kenneth C. Frazier, Chairman, President and CEO of Merck & Co, Inc., as Board treasurer. (Logo:...

2013-04-11 12:30:41

PhRMA Member Companies Invested $48.5 Billion in R&D in 2012 WASHINGTON, April 11, 2013 /PRNewswire-USNewswire/ -- Investment in research and development (R&D) by member companies of the Pharmaceutical Research and Manufacturers of America (PhRMA) remained strong at an estimated $48.5 billion in 2012, despite economic, scientific, and business challenges. These efforts are highlighted in PhRMA's 2013 Biopharmaceutical Research Industry Profile released today. (Logo:...

2013-03-25 16:22:50

Research Supported by Biopharmaceutical Companies is Boost to Texas Economy WASHINGTON, March 25, 2013 /PRNewswire/ -- Working in collaboration with university medical schools and science centers, local hospitals and clinical research facilities, America's biopharmaceutical companies have conducted more than 8,200 clinical trials of new medicines in Texas over the last 13 years, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA). The...

2013-03-11 12:25:10

More Than 900 Biologic Medicines and Vaccines in Development WASHINGTON, March 11, 2013 /PRNewswire-USNewswire/ -- America's biopharmaceutical companies are using biological processes to develop 907 medicines and vaccines targeting more than 100 diseases, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA). (Logo: http://photos.prnewswire.com/prnh/20091027/PHRMALOGO) The report includes biologics in human clinical trials or...

2013-01-17 12:27:08

Report underscores value of innovation for patients with unmet medical needs WASHINGTON, Jan. 17, 2013 /PRNewswire-USNewswire/ -- The biopharmaceutical pipeline is innovative and robust, with a high proportion of potential first-in-class medicines and therapies targeting diseases with limited treatment options, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA). (Logo: http://photos.prnewswire.com/prnh/20091027/PHRMALOGO) Watch...

2012-09-12 10:25:37

WASHINGTON, Sept. 12, 2012 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today on proposed changes to Medicaid in Louisiana: (Logo: http://photos.prnewswire.com/prnh/20091027/PHRMALOGO ) "Seeking new approaches to coordinate care for Medicaid and LaCHIP recipients is critically important. However, without proper protections for patients, the Louisiana Department of Health and...

2012-09-07 06:24:11

Recipients recognized for outstanding contributions to the fight against Alzheimer's disease WASHINGTON, Sept. 7, 2012 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today the recipients of the first annual Research and Hope Awards. This year's award honors outstanding achievements in academia, the biopharmaceutical research sector, as well as the patient and caregiving communities to help advance medical progress and patient care...